Literature DB >> 8811218

Iritis following intravenous pamidronate.

G O Stewart1, B G Stuckey, L C Ward, R L Prince, D H Gutteridge, I J Constable.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8811218     DOI： 10.1111/j.1445-5994.1996.tb01932.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN： 0004-8291


× No keyword cloud information.
  8 in total

Review 1.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Tolerability of intravenous pamidronate for the treatment of osteoporosis and other metabolic osteopathies: A retrospective analysis.

Authors:  Marcelo Sarli; Rodolfo Spivacow; Viviana Pedroarias; Emilio J A Roldán; José R Zanchetta
Journal:  Curr Ther Res Clin Exp       Date:  2007-01

Review 3.  The role of bisphosphonates in multiple myeloma.

Authors:  Jessica Levy; G David Roodman
Journal:  Curr Hematol Malig Rep       Date:  2009-04       Impact factor: 3.952

Review 4.  Comparative tolerability of drug therapies for hypercalcaemia of malignancy.

Authors:  N Zojer; A V Keck; M Pecherstorfer
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

5.  Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England.

Authors:  Beate Aurich-Barrera; Lynda Wilton; Scott Harris; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 6.  Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.

Authors:  A J Coukell; A Markham
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

Review 7.  Risedronate-associated scleritis: a case report and review of the literature.

Authors:  Iman Hemmati; John Wade; John Kelsall
Journal:  Clin Rheumatol       Date:  2012-08-05       Impact factor: 2.980

8.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.